Anika Therapeutics | ANIK - PE Price to Earnings


Anika Therapeutics reported 47.54 in PE Price to Earnings for its fiscal quarter ending in June of 2024.





Pe Change Date
Abbott 24.94 5.78 Mar/2026
Agios Pharmaceuticals 3.56 0 Mar/2026
Anika Therapeutics 47.54 27.2 Jun/2024
Halozyme Therapeutics 23.16 7.7 Dec/2025
Integra LifeSciences 5.07 1.52 Mar/2026
Intrexon 7.54 221.44 Dec/2021
J&J 24.53 0.91 Mar/2026
Ligand Pharmaceuticals 60.65 17.62 Sep/2025
Merit Medical Systems 45.2 6.08 Dec/2025
Rigel Pharmaceuticals 8.61 8.4 Mar/2025
Sanofi 11.84 0.14 Mar/2026
Smith & Nephew 17.63 4.2 Dec/2025
Stryker 30.44 1.69 Mar/2026
Surmodics 386.18 225.66 Dec/2021
Veracyte 45.3 5.4 Dec/2025
Xencor 29.92 3.22 Sep/2022
Zimmer Biomet Holdings 25.47 7.56 Mar/2026